Rhythm Biosciences Limited (FRA:0RY)

Germany · Delayed Price · Currency is EUR

0.0575

+0.0030 (5.50%)

At close: Jun 26, 2026

82.54% (1Y)

Market Cap	21.42M +125.2%
Revenue (ttm)	936.11K -48.0%
Net Income	-3.79M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0575
Previous Close	0.0545
Day's Range	0.0575 - 0.0575
52-Week Range	0.0270 - 0.1440
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Rhythm Biosciences

Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia and the United States. It offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic disease development. The company was incorporated in 2017 and is headquartered in Parkville, Australia. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances

Founded 2017

Country Australia

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 0RY

Financial Performance

In fiscal year 2025, Rhythm Biosciences's revenue was 3.19 million, an increase of 88.85% compared to the previous year's 1.69 million. Losses were -3.83 million, -44.15% less than in 2024.

Financial numbers in AUD Financial Statements